Specialized Screening Tests
At FOUNTYLAB, we focus on prevention through advanced screening tests. Early detection of diseases allows for faster and more effective treatment, thus reducing the risk of complications and improving patient prognosis.
Our screening tests are designed to quickly identify specific pathologies even before the first symptoms appear. Thanks to precise and reliable analyses, we help our patients better anticipate their state of health and act in time.
Early Analysis for Effective Prevention
The FOUNTYLAB laboratory offers a wide range of screening tests adapted to various medical needs. Whether for infections, metabolic disorders or chronic diseases, we provide high-performance diagnostic solutions for optimal monitoring.
Screening Tests Offered by the Laboratory..
These specialized tests reflect our commitment to delivering high-level scientific accuracy, supported by state-of-the-art equipment and a team of experts.
PSA (Prostate-Specific Antigen): Screening for prostate cancer.
CA-125: Detection of ovarian cancers.
CA 15-3: Indicator of breast cancer, useful for monitoring.
CA 19-9: Marker associated with pancreatic cancer and sometimes other digestive cancers.
CEA (Carcinoembryonic Antigen): Screening for colorectal and some digestive tumors.
Alpha-Fetoprotein (AFP): Detection of liver cancer (hepatocarcinoma) and germ cell tumors.
HIV (Human Immunodeficiency Virus): Screening and confirmation test.
Viral Hepatitis (B and C): Serology to detect acute or chronic infections. Syphilis: Screening test (TPHA, VDRL).
Chlamydia trachomatis and Mycoplasma genitalium: Detection by PCR targeting a group of microorganisms responsible for sexually transmitted infections (STIs).
Human Papillomavirus (HPV): Detection of high-risk oncogenic strains.
Cytomegalovirus (CMV): Screening for latent or congenital infections.
Toxoplasmosis and Rubella: Screening as part of prenatal care.
Toxoplasmosis: Screening for Toxoplasma gondii infections.
Rubella: Serology to assess immunity or detect active infection.
Syphilis: Screening for syphilitic infections in pregnant women.
CMV (Cytomegalovirus): Detection of CMV infection, which can cause congenital malformations.
Hepatitis B and C: Serology to prevent vertical transmission to the fetus.
Fasting Blood Sugar and Glycated Hemoglobin (HbA1c): For diabetes screening and monitoring.
HOMA Index (Homeostasis Model Assessment): Evaluation of insulin resistance and beta-cell function.
Plasma Insulin Measurement: To detect hyperinsulinemia or insulin resistance.
Lipid Profile: Analysis of total cholesterol, LDL, HDL, and triglycerides to screen for dyslipidemia and assess cardiovascular risk.
Thyroid Function (TSH, T3, Free T4): To screen for hypo- or hyperthyroidism.
Prolactin: Detection of disorders related to hyperprolactinemia.
Sex Hormones: Evaluation of estradiol, testosterone, and FSH/LH levels to diagnose hormonal disorders related to fertility or menstrual cycle.
Cortisol: Screening for adrenal gland disorders, such as Cushing's syndrome or adrenal insufficiency.
Growth Hormone (GH) and IGF-1: Detection of growth disorders and associated metabolic abnormalities.
Bone Disorders: Measurement of calcium, phosphate, vitamin D, and parathyroid hormone (PTH) to detect bone metabolism disorders.
Hemostasis Disorders: Coagulation profile (PT, aPTT, fibrinogen, D-dimers) to detect blood coagulation abnormalities.
Specific Tests and Pre-Analytical Condition
- Glycemic Profile: Fast for 8 to 12 hours before collection.
- Lipid Profile: A 12-hour fast is recommended for optimal results.
- Prolactin: Collect the sample while fasting, with a minimum of 30 minutes of rest before collection.
- Cortisol: Collect at 8 a.m., when levels are highest, or at 4 p.m. according to medical prescription (circadian rhythm).
-
Hormonal Profile (e.g., LH, FSH):
• Follow specific indications depending on the menstrual cycle day for certain hormones (LH, FSH).
• Inform staff of any hormonal treatment intake.
General Instructions
Patients are advised to request information regarding the pre-analytical phase before undergoing their tests. This ensures that all necessary instructions are followed for an accurate diagnosis.
FOUNTY LAB
